-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 4, 2021, Guizhou Braun Group issued an announcement that its subsidiary, Herentang Pharmaceutical, was fined RMB 32,068,379.
01 Production process is illegal
01 Production process is illegalCompany announcement shows that recently, Guizhou Braun Enterprise Group Pharmaceutical Co.
When Herentang Pharmaceutical produces the drug "Kangfuling Capsules", it illegally extracts the cork extract powder and adds it to ensure that the product content meets the standard requirements
02 illegal facts
02 illegal factsThe Guiyang Municipal Market Supervision Administration's announcement on the punishment of the case of Herentang Pharmaceutical Co.
After discussion, it was decided to extract Phellodendron chinense according to the extraction process of Kangfuling capsule Chinese medicinal materials and store it in the buffer room of the logistics channel of the Herentang capsule production workshop.
In the process of using the capsule production line to produce Kangfuling capsules, Herentang inspects the first batch of intermediate products using the same batch of raw cork.
After investigation, from May 2018 to January 2019, a total of 36 batches of Kangfuling capsules were supplemented with cork dry ointment powder in violation of regulations (33 batches of finished products and 3 batches of closed finished products)
The company illegally joined the 33 batches of Kangfuling capsules produced by the dry extract powder of Phellodendron chinense, a total of 1532030 boxes, of which 15 boxes were sampled by the former Guizhou Food and Drug Administration, and 135 boxes were used by employees; the remaining 1531880 boxes have been sold
03 Half of the revenue was confiscated due to illegality
03 Half of the revenue was confiscated due to illegalityIn view of the fact that Herentang Pharmaceuticals violated the law for the first time and voluntarily recalled the batch of products involved, and has not received any new adverse reaction report of the batch of products involved, it complies with Article 32, Paragraph 1, Article 32 of the Administrative Punishment Law of the People’s Republic of China.
At the same time, it actively cooperated with Rentang Pharmaceutical Co.
According to regulations, the Guiyang City Market Supervision Administration ordered Herentang Pharmaceutical to immediately stop the illegal activities, and imposed reduced administrative penalties as follows:
1.
2.
Public information shows that Kangfuling Capsule is the exclusive product of Herentang Pharmaceutical
Coincidentally, on November 19, 2021, Guangxi Jinhaitang Pharmaceutical Co.